Pain Nurse Administration Pain Outpatient Clinic Anja Frings Cem Gül Monday to Friday from 9 a.m. to 1 p.m. Tel. 0511 532 3108 Fax 0511-532-8109 Email: S chmerza mbulanz@mh-hannover.de
Clinical Department of Gastroenterology, Hepatology, Infectiology and Endocrinology Carl-Neuberg-Str. 1 30625 Hannover Director: Prof. Dr. med. Heiner Wedemeyer Office: Sabrina Claußen Tel.+49 511 532 3305
Department of Anaesthesiology and Intensive Care Medicine Prof. Dr. med. Björn Jüttner Carl-Neuberg-Strasse 1 30625 Hannover Email tauchmedizin @ mh-hannover.de Diving consultation (diving fitness examinations):
511 532 -2753 (office), -3654 (lab) Fax: +49 511 532-161215 Adresse: 30625 Hannover, Carl-Neuberg-Str.1, Germany Building J03, level 03, room 1270 ► Profil bei ResearchGate Career 2019: Senior Scientist, [...] Institute of Molecular and Cell Physiology, Hannover Medical School; Research and Development topics: (1) Application of biophysical stimuli to promote myofibrillar maturation of human pluripotent stem ce [...] cardiac samples and pluripotent stem cell-derived cardiomyocyte models. 2013-2019 : Juniorprofessor (W1 position) for “Muscle Physiology and Pathophysiology”, Institute of Molecular and Cell Physiology, Hannover
patient care at both university medical centres, the state had set up a special fund with a volume of 2.1 billion euros. This is currently the largest construction project in Lower Saxony and probably one of [...] new building and when and in which construction phase. Within the framework of the special funds of 1.05 billion euros available for the MHH, it was also determined how many square metres of floor space
addition, further new biomarkers are to be identified over the next five years. 1,000 affected persons are included in the study About 1,000 patients will be recruited for P4D at the five participating university
stroke unit is a special ward for the treatment of strokes. Last year, about 1,100 patients with apoplexy were treated here. Around 1,800 patients were also treated via the MHH Teleneurology Network. The MHH
antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study. European heart journal, 42(2), 178-188. https://doi [...] Preclinical development of a miR-132 inhibitor for heart failure treatment. Nature communications, 11(1), 633. https://doi.org/10.1038/s41467-020-14349-2
Institute for Ethics, History and Philosophy of Medicine OE 5450 Hannover Medical School Carl-Neuberg-Str. 1 D-30625 Hannover Phone: +49 511-532-8295 Email: prince.ilvie @ mh-hannover.de Ilvie Prince studied [...] crucial differentiation between ethical and social aspects in health technology assessment. ZEFQ 164, 1–10. Publications (not peer-reviewed): Schnell-Inderst, P., Steigenberger, C., Mertz, M., Otto, I. ,
on primary hemostasis and platelet function will be characterized in the flow chamber model (Figure 1) and other assays (e.g. cell culture) to better understand the severe bleeding tendency in acquired [...] Hart C, Pfrepper C, Knöbl P, Greil R, Neumeister P, Reipert BM, Tiede A. Blood Adv. 2023 Jan 10;7(1):122-130. Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Tiede A, Sachs UJ, Czwalinna